secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2025-02-21T23:59:59+00:00
Accession:  0001104659-25-016181
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Petros Pharmaceuticals Prices $9.6 Million Public Offering of Common Stock and Warrants
--------------------------------------------------------------------------------

- Petros Pharmaceuticals entered securities purchase agreement for 13,950,012 units and 26,049,988 pre-funded units at $0.24 and $0.2399 per unit.
- Offering closed on February 19, 2025, with gross proceeds of approximately $9.6 million.
- Each unit includes one share (or pre-funded warrant), one Series A warrant (0.25 share) and one Series B warrant (1 share) at $0.48 exercise price.
- Warrants exercisable only upon stockholder approval; pre-funded warrants immediately exercisable at $0.0001 per share.
- Company granted 1,000,000, 300,000, 150,000, 450,000, 150,000, and 150,000 restricted shares to directors Silverman, Bernstein, Walker, Boctor, Arnold, and Weinstein.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465925016181/0001104659-25-016181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465925016181/tm257154d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-016181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer